Abstract:Objective To analyze the value of conventional ultrasound combined with contrast-enhanced ultrasound in differentiating benign from malignant renal tumors.Methods One hundred and forty-one patients (145 lesions) with renal space-occupying lesions who were admitted to the First Affiliated Hospital of University of Science and Technology of China from March 2020 to February 2023 were selected. They were all examined by conventional color Doppler ultrasound and contrast-enhanced ultrasound. The results of ultrasound-guided biopsy or pathological examination on tissues obtained from surgery were taken as the gold standard to analyze the consistency and efficiency (sensitivity, specificity, accuracy, positive predictive value and negative predictive value) of conventional ultrasound and contrast-enhanced ultrasound in the differential diagnosis of benign and malignant renal tumors. The patients were divided into benign group and malignant group according to the gold standard. The conventional ultrasound parameters [Finkler ultrasound score and blood flow resistance index (RI) ] and the contrast-enhanced ultrasound parameters [area under the curve (AUC), time to peak (TTP), peak intensity (PI), basic intensity (BI), and arrival time (AT) ]. The receiver operating characteristic (ROC) curve was plotted to analyze the value of the combination of conventional ultrasound parameters and contrast-enhanced ultrasound parameters in the differential diagnosis of benign and malignant renal tumors.Results The results of conventional ultrasound in differentiating benign and malignant renal tumors were in a great agreement with pathological findings (Kappa = 0.581, P < 0.05), while the results of contrast-enhanced ultrasound in differentiating benign and malignant renal tumors were in an excellent agreement with pathological findings (Kappa = 0.804, P < 0.05). The diagnostic sensitivity, accuracy and negative predictive value of contrast-enhanced ultrasound were higher than those of conventional ultrasound (P < 0.05). There was no difference in the specificity and positive predictive value between contrast-enhanced ultrasound and conventional ultrasound (P > 0.05). The Finkler ultrasound score and AUC of the malignant group were higher than those of the benign group, while the RI and PI of the malignant group were lower than those of the benign group (P < 0.05). The TTP of the malignant group was shorter than that of the benign group (P < 0.05). There was no difference in BI and AT between the malignant group and the benign group (P > 0.05). The ROC curve showed that the sensitivity of Finkler ultrasound score was 82.8% (95% CI: 0.784, 0.923) and the specificity was 73.9% (95% CI: 0.792, 0.929). The sensitivity of RI was 86.1% (95% CI: 0.798, 0.961) and the specificity was 73.9% (95% CI: 0.802, 0.958). The sensitivity of AUC was 87.7% (95% CI: 0.887, 0.969) and the specificity was 82.6% (95% CI: 0.873, 0.946). The sensitivity and specificity of TTP were 80.8% (95% CI: 0.706, 0.910) and 69.6% (95% CI: 0.713, 0.915). The sensitivity of PI was 85.2% (95% CI: 0.802, 0.936) and the specificity was 73.9% (95% CI: 0.809, 0.941). The sensitivity and specificity of the combined detection in differentiating benign and malignant renal tumors were 95.1% (95% CI: 0.876, 0.995) and 69.6% (95% CI: 0.864, 0.986).Conclusions Conventional ultrasound combined with contrast-enhanced ultrasound could increase the detection rate of malignant renal tumors, and the combination of quantitative parameters of the two approaches effectively aids in differentiating benign from malignant renal tumors.